Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX354-C in subjects with rheumatoid arthritis
ISRCTN50655730Phase 2Completed
- Sponsor
- ChemoCentryx
- Start
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of CCX354 in rheumatoid arthritis (RA), sponsored by ChemoCentryx. Started Dec 2009; status: completed.
02
Drugs
CCX354
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN50655730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN50655730.